NO20011103D0 - Lokal avlevering av legemidler til hjertet - Google Patents

Lokal avlevering av legemidler til hjertet

Info

Publication number
NO20011103D0
NO20011103D0 NO20011103A NO20011103A NO20011103D0 NO 20011103 D0 NO20011103 D0 NO 20011103D0 NO 20011103 A NO20011103 A NO 20011103A NO 20011103 A NO20011103 A NO 20011103A NO 20011103 D0 NO20011103 D0 NO 20011103D0
Authority
NO
Norway
Prior art keywords
medicines
heart
local delivery
delivery
local
Prior art date
Application number
NO20011103A
Other languages
English (en)
Norwegian (no)
Inventor
Stephen D Pacetti
Thomas B Ottoboni
Ronald K Yamamoto
Original Assignee
Point Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Point Biomedical Corp filed Critical Point Biomedical Corp
Publication of NO20011103D0 publication Critical patent/NO20011103D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20011103A 1998-09-02 2001-03-02 Lokal avlevering av legemidler til hjertet NO20011103D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9897598P 1998-09-02 1998-09-02
PCT/US1999/020388 WO2000012062A1 (fr) 1998-09-02 1999-09-02 Administration locale d'un medicament pour le coeur

Publications (1)

Publication Number Publication Date
NO20011103D0 true NO20011103D0 (no) 2001-03-02

Family

ID=22271802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011103A NO20011103D0 (no) 1998-09-02 2001-03-02 Lokal avlevering av legemidler til hjertet

Country Status (5)

Country Link
EP (1) EP1109531A1 (fr)
AU (1) AU6027899A (fr)
CA (1) CA2342912A1 (fr)
NO (1) NO20011103D0 (fr)
WO (1) WO2000012062A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6896659B2 (en) 1998-02-06 2005-05-24 Point Biomedical Corporation Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
US6334859B1 (en) 1999-07-26 2002-01-01 Zuli Holdings Ltd. Subcutaneous apparatus and subcutaneous method for treating bodily tissues with electricity or medicaments
US6969382B2 (en) 1999-07-26 2005-11-29 Zuli Holdings, Ltd. Method and apparatus for treating bodily tissues with medicinal substance
EP1202671A4 (fr) * 1999-08-13 2004-11-10 Point Biomedical Corp Microparticules utiles en tant qu'agents de contraste sous l'effet d'ultrasons pour le systeme lymphatique
WO2001012069A1 (fr) 1999-08-13 2001-02-22 Point Biomedical Corporation Microspheres creuses a fragilite controlee a usage medical
US6740039B1 (en) 1999-08-20 2004-05-25 Koninklijke Philips Electronics N.V. Methods and apparatus for displaying information relating to delivery and activation of a therapeutic agent using ultrasound energy
US6527718B1 (en) 1999-08-20 2003-03-04 Brian G Connor Ultrasound system for continuous imaging and delivery of an encapsulated agent
WO2008110958A1 (fr) 2007-03-09 2008-09-18 Koninklijke Philips Electronics N.V. Procédé de commande de la libération d'un matériau porté par des particules sensibles aux ultrasons

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US5650156A (en) * 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders

Also Published As

Publication number Publication date
EP1109531A1 (fr) 2001-06-27
CA2342912A1 (fr) 2000-03-09
WO2000012062A1 (fr) 2000-03-09
AU6027899A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
FI972292A0 (fi) Administrering av diabetes
DK1208864T3 (da) Forbedringer til lægemiddelafgivelsesindretninger
ATE313317T1 (de) Herstellung von therapeutischem mikroschaum
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
DE60018777D1 (de) Medikamentenversorgung der sub-tenon
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
DE69829554D1 (de) Ovalgefortme herzkanüle
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO20013958D0 (no) Legemiddel til behandling av hoyt blodtrykk
NO20021090L (no) Farmasöytiske opplösninger av levosimendan
DE60019960D1 (de) Herstellung von isobutencopolymere
DK1275397T3 (da) Lægemiddel til lokal anvendelse
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
TR199501501A2 (tr) Sekerlemelerin hazirlanmasi.
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20020784L (no) Medikament for behandling av brudd
PT964867E (pt) Antagonistas da taquicinima
NO20014081D0 (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
EA199900672A1 (ru) Гомеопатическое лекарственное средство
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner